跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Bimekizumab Injection
Approved
生物制品
Bimekizumab Injection
UCB-Pharma SA
🇨🇳 National Medical Products Administration
Approval Date
Jul 16, 2024
Approval ID
8beaLyAx1XT
Company
UCB-Pharma SA
Type
生物制品
Approval Details
Approval Id
8beaLyAx1XT
Approval Number
国药准字SJ20240031
Generic Name
比奇珠单抗注射液
Generic Name En
Bimekizumab Injection
Trade Name
倍捷乐
Drug Type
生物制品
Dosage Form
注射剂
Strength
预充式注射笔装:160mg(1.0ml)/支
Reg Date
2024-07-16
Expired Date
2029-07-15
Company Name
UCB-Pharma SA
Production Company Name
UCB-Pharma SA
Company Detail Path
/organization/ucb-pharma-sa-switzerland
Production Company Detail Path
/organization/ucb-pharma-sa-switzerland
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 16, 2024
Approval ID
8beaLyAx1XT
Type
生物制品
Back to NMPA Approvals
倍捷乐 - NMPA Drug Approval Details